Related Experiment Video
Updated: Jul 12, 2026

Stress-induced Antibiotic Susceptibility Testing on a Chip
Published on: January 8, 2014
US Food and Drug Administration Seeks Input From Healthcare Technology Management Community on Medical Device Supply
Abstract:
The US Food and Drug Administration (FDA) is currently seeking information from the clinical community about existing and anticipated disruptions in the supply of medical devices related to COVID-19. This information is important to FDA's fulfillment of its mission to ensure that healthcare providers and patients have continued access to safe and effective medical products. Insights from the clinical community, including clinical engineers and biomedical equipment technicians, bring device supply issues experienced on the front lines to FDA's attention so that the FDA can develop effective strategies to prevent and mitigate medical device supply concerns in its continued response to the COVID-19 public health emergency. Here, we describe the public health impact of the clinical perspective and the type of information that the FDA is seeking regarding current or anticipated medical device supply concerns. Information about how to have your voice heard on this important matter is included at the end of this article.
More Related Videos
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
FDA Approved Drugs: Changes to Approved Drugs
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Investigation of Disease Outbreaks

